RT Journal Article
SR Electronic
T1 The impact of community asymptomatic rapid antigen testing on COVID-19 hospital admissions: a synthetic control study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.19.22274050
DO 10.1101/2022.04.19.22274050
A1 Zhang, Xingna
A1 Barr, Ben
A1 Green, Mark
A1 Hughes, David
A1 Ashton, Matthew
A1 Charalampopoulos, Dimitrios
A1 García-Fiñana, Marta
A1 Buchan, Iain
YR 2022
UL http://medrxiv.org/content/early/2022/04/21/2022.04.19.22274050.abstract
AB Objective To analyse the impact on hospital admissions for COVID-19 of large-scale, voluntary, public open access rapid testing for SARS-CoV-2 antigen in Liverpool (UK) between 6th November 2020 and 2nd January 2021.Design Synthetic control analysis comparing hospital admissions for small areas in the intervention population to a group of control areas weighted to be similar in terms of prior COVID-19 hospital admission rates and socio-demographic factors.Intervention COVID-SMART (Systematic Meaningful Asymptomatic Repeated Testing), a national pilot of large-scale, voluntary rapid antigen testing for people without symptoms of COVID-19 living or working in the City of Liverpool, deployed with the assistance of the British Army from the 6th November 2020 in an unvaccinated population. This pilot informed the UK roll-out of SARS-CoV-2 antigen rapid testing, and similar policies internationally.Main outcome measure Weekly COVID-19 hospital admissions for neighbourhoods in England.Results The intensive introduction of COVID-SMART community testing was associated with a 43% (95% confidence interval: 29% to 57%) reduction in COVID-19 hospital admissions in Liverpool compared to control areas for the initial period of intensive testing with military assistance in national lockdown from 6th November to 3rd December 2020. A 25% (11% to 35%) reduction was estimated across the overall intervention period (6th November 2020 to 2nd January 2021), involving fewer testing centres, before England’s national roll-out of community testing, after adjusting for regional differences in Tiers of COVID-19 restrictions from 3rd December 2020 to 2nd January 2021.Conclusions The world’s first voluntary, city-wide SARS-CoV-2 rapid antigen testing pilot in Liverpool substantially reduced COVID-19 hospital admissions. Large scale asymptomatic rapid testing for SARS-CoV-2 can help reduce transmission and prevent hospital admissions.What is already known on this topic– Previous studies on managing the spread of SARS-CoV-2 have identified asymptomatic transmission as significant challenges for controlling the pandemic.– Along with non-pharmaceutical measures, many countries rolled out population-based asymptomatic testing programmes to further limit transmission.– Evidence is required on whether large scale voluntary testing of communities for COVID-19 reduces severe disease, by breaking chains of transmission.What this study adds– The findings of this study suggest that large scale rapid antigen testing of communities for SARS-CoV-2, within an agile local public health campaign, can reduce transmission and prevent hospital admissions.– The results indicate that policy makers should integrate such testing into comprehensive, local public health programmes targeting high risk groups, supporting those required to isolate and adapting promptly to prevailing biological, behavioural and environmental circumstances.Competing Interest StatementThe City of Liverpool received a donation from Innova Medical Group towards the foundation of the Pandemic Institute. None of this funding has supported the research reported here or any of the authors' work to date.Funding StatementThis report is independent research funded by the Department of Health and Social Care. This work was supported by the Economic and Social Research Council [grant number ES/L011840/1]. IB is supported by the National Institute for Health Research as Senior Investigator. BB, XZ are supported by the NIHR Applied Research Collaboration North West Coast (ARC NWC). IB, BB and XZ are also supported by the National Institute for Health Research (NIHR) Health Protection Research Unit in Gastrointestinal Infections, a partnership between Public Health England, the University of Liverpool and the University of Warwick (Grant No: NIHR ref NIHR200910). The NIHR had no role in the study design, data collection and analysis, decision to publish or preparation of the article. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, NIHR or the Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the data we used are publicly accessible from https://coronavirus.data.gov.uk/.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data we used are publicly accessible from https://coronavirus.data.gov.uk/ and statistical code is available from the corresponding author upon request.